Femasys appoints John Canning as COO; base $450K, inducement option 150K shares

FEMASYS INC

John Canning appointed COO effective March 30, 2026; annual base salary $450,000 with 40% target bonus.
Canning previously COO at Terumo Aortic (2017-2026) and Bolton Medical, with 25+ years MedTech experience.
Granted inducement stock option for 150,000 shares at closing price on grant date; vesting 25% annually over 4 years.
Appointment aims to strengthen operational capabilities and support commercial growth of FemBloc and FemaSeed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.